IPO
IPO: Decipher Biosciences Advances Prostate Genomic Testing
Decipher Biosciences, a commercial-stage precision urology oncology company, has filed with the U.S. Securities and Exchange Commission (SEC) to raise...
DISCOVERIES
Here Is A New Class Of RNA Therapeutics
The approval in 2018 of a new drug to treat polyneuropathy caused by a rare and frequently fatal disease called hereditary transthyretin-mediated amy...
STARTUPS
What Illumina Ventures’ Portfolio Says About The Science And Business Models Of The Future Care Delivery System
A look inside a leading venture capital firm’s portfolio is like a lens for understanding the current state of the future of healthcare. Illumin...
SCIENCE
FDA: Artificial Intelligence/Machine Learning (AI/ML)-Based Software As A Medical Device (SaMD)
Human biology and new, more advanced computing is creating new territory for therapies that were not capable even five years ago. Artificial intellige...
